myelofibrosis
Showing NaN - NaN of 45
Acute Myeloid Leukemia, MDS, Agnogenic Myeloid Metaplasia Trial in Houston (Dasatinib (BMS-354825))
Completed
- Acute Myeloid Leukemia
- +7 more
- Dasatinib (BMS-354825)
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
May 2, 2019
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose
Terminated
- Lymphoma, Large B-Cell, Diffuse
- +20 more
- ASN002 Dose Escalation
- ASN002 RD
-
Tempe, Arizona
- +13 more
Aug 13, 2018
Myelofibrosis Trial in Worldwide (Placebo, Ruxolitinib, Vismodegib)
Completed
- Myelofibrosis
- Placebo
- +2 more
-
Fort Myers, Florida
- +12 more
May 4, 2018
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,
Terminated
- Myelodysplastic Syndrome
- +9 more
-
Phoenix, Arizona
- +6 more
Feb 13, 2018
Myelofibrosis Trial in United States (SAR302503 (TG101348))
Completed
- Myelofibrosis
- SAR302503 (TG101348)
-
La Jolla, California
- +5 more
Feb 17, 2016
Myelofibrosis Trial in United States (bevacizumab (Avastin))
Terminated
- Myelofibrosis
- bevacizumab (Avastin)
-
Washington, District of Columbia
- +4 more
Aug 8, 2014
Myelofibrosis Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))
Completed
- Myelofibrosis
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +6 more
Aug 16, 2013
Myelofibrosis Trial in Houston (Azacitidine)
Completed
- Myelofibrosis
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Leukemia, Myelofibrosis Trial in Houston (CEP-701)
Completed
- Leukemia
- Myelofibrosis
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Jun 19, 2012
Bone Marrow Transplant Chart Review for RIC
Completed
- Myelofibrosis
- Reduced Intensity Conditioning (RIC) Allogenic Transplant
-
Houston, Texas
- +3 more
Oct 8, 2009